Ciaftalan

Ciaftalan

SCHEMBL1019853

F.F.[Ti].c1ccc2c(c1)-c1nc-2nc2[nH]c(nc3nc(nc4[nH]c(n1)c1ccccc41)-c1ccccc1-3)c1ccccc21

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
TDP1 Q9NUW8 4/20 0.44
RECQL P46063 3/20 0.44
THRB P10828 1/20 0.44
APEX1 P27695 1/20 0.44
BLM P54132 1/20 0.44
CA5A P35218 1/20 0.39
CYP1A2 P05177 4/20 0.34
CYP2D6 P10635 4/20 0.34
CYP2C19 P33261 4/20 0.34
CYP3A4 P08684 3/20 0.34
HSD17B10 Q99714 3/20 0.34
USP2 O75604 1/20 0.34
ALOX15 P16050 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
ALDH1A1 P00352 3/20 0.33
MAPK1 P28482 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ciaftalan SCHEMBL1201402 0.98 MEN1 (0.45) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL6300584 0.98 MEN1 (0.45) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL194875 0.98 MEN1 (0.45) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL1019072 0.98 MEN1 (0.45) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL9068243 0.96 MEN1 (0.44) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL5826831 0.96 MEN1 (0.44) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL10618089 0.96 MEN1 (0.44) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL1023666 0.96 MEN1 (0.44) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL29005981 0.96 MEN1 (0.44) MEN1KMT2ATDP1RECQLTHRB
Ciaftalan SCHEMBL29010398 0.96 MEN1 (0.44) MEN1KMT2ATDP1RECQLTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080177060-A1 Use of axial substituted phthalocyanine compoud for preparing organic thin-film transistor CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 2008-07-24 US claimed
US-7871855-B2 Use of axial substituted phthalocyanine compound for preparing organic thin-film transistor CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 2011-01-18 US disclosed
US-20080177060-A1 Use of axial substituted phthalocyanine compoud for preparing organic thin-film transistor CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080177060-A1 Use of axial substituted phthalocyanine compoud for preparing organic thin-film transistor OCIAD2, EED, SLCO4C1 MEN1 1239/4885KMT2A 752/4885TDP1 4766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.